Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-02 4:15 pm Purchase |
2023-12-21 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Point72 Asset Management, L.P. | 1,471,771 5.700% |
1,471,771 (New Position) |
Filing History |
| 2023-12-28 4:15 pm Purchase |
2023-12-27 | 13G | PagSeguro Digital Ltd. PAGS |
Point72 Asset Management, L.P. | 10,702,598 5.100% |
8,012,692 (+297.88%) |
Filing History |
| 2023-12-18 4:15 pm Purchase |
2023-12-07 | 13G | Protagonist Therapeutics, Inc. PTGX |
Point72 Asset Management, L.P. | 3,186,077 5.500% |
2,818,071 (+765.77%) |
Filing History |
| 2023-12-11 4:15 pm Purchase |
2023-11-29 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
Point72 Asset Management, L.P. | 3,470,691 5.100% |
3,470,691 (New Position) |
Filing History |
| 2023-12-01 4:15 pm Purchase |
2023-11-30 | 13G | FARFETCH LTD FTCHQ |
Point72 Asset Management, L.P. | 18,765,409 5.300% |
18,765,409 (New Position) |
Filing History |
| 2023-11-20 4:15 pm Purchase |
2023-11-10 | 13G | Celldex Therapeutics, Inc. CLDX |
Point72 Asset Management, L.P. | 3,622,136 6.600% |
3,622,136 (New Position) |
Filing History |
| 2023-11-16 5:00 pm Purchase |
2023-11-15 | 13G | Lyra Therapeutics, Inc. LYRA |
Point72 Asset Management, L.P. | 3,000,000 5.400% |
3,000,000 (New Position) |
Filing History |
| 2023-11-09 4:27 pm Purchase |
2023-11-03 | 13G | Korro Bio, Inc. KRRO |
Point72 Asset Management, L.P. | 542,657 6.800% |
542,657 (New Position) |
Filing History |
| 2023-10-31 4:26 pm Purchase |
2023-10-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Point72 Asset Management, L.P. | 3,520,402 5.100% |
3,520,402 (New Position) |
Filing History |
| 2023-10-20 4:15 pm Purchase |
2023-10-19 | 13G | Semtech Corporation SMTC |
Point72 Asset Management, L.P. | 4,660,836 7.300% |
4,660,836 (New Position) |
Filing History |
| 2023-10-18 4:15 pm Purchase |
2023-10-17 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
Point72 Asset Management, L.P. | 4,061,343 5.100% |
4,061,343 (New Position) |
Filing History |
| 2023-10-10 4:59 pm Purchase |
2023-10-09 | 13G | Madison Square Garden Entertainment Corp. MSGE |
Point72 Asset Management, L.P. | 2,303,613 5.600% |
2,303,613 (New Position) |
Filing History |
| 2023-10-10 4:05 pm Purchase |
2023-09-29 | 13G | Rapid7, Inc. RPD |
Point72 Asset Management, L.P. | 3,092,270 5.100% |
3,092,270 (New Position) |
Filing History |
| 2023-10-05 4:47 pm Purchase |
2023-10-04 | 13G | VistaGen Therapeutics, Inc. VTGN |
Point72 Asset Management, L.P. | 1,565,829 5.600% |
1,565,829 (New Position) |
Filing History |
| 2023-10-05 4:24 pm Purchase |
2023-10-04 | 13G | TPI Composites, Inc. TPIC |
Point72 Asset Management, L.P. | 2,132,171 5.000% |
2,132,171 (New Position) |
Filing History |
| 2023-10-02 4:45 pm Purchase |
2023-09-29 | 13G | Morphic Holding, Inc. MORF |
Point72 Asset Management, L.P. | 2,504,383 5.200% |
2,504,383 (New Position) |
Filing History |
| 2023-09-29 4:33 pm Purchase |
2023-09-28 | 13G | Bionomics Limited BNOX |
Point72 Asset Management, L.P. | 9,924,390 8.100% |
9,924,390 (New Position) |
Filing History |
| 2023-09-18 4:24 pm Purchase |
2023-09-15 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Point72 Asset Management, L.P. | 3,727,952 5.600% |
3,727,952 (New Position) |
Filing History |
| 2023-09-15 5:11 pm Purchase |
2023-09-14 | 13G | Cybin Inc. CYBN |
Point72 Asset Management, L.P. | 498,684 8.100% |
498,684 (New Position) |
Filing History |
| 2023-07-27 4:20 pm Purchase |
2023-07-25 | 13G | Turnstone Biologics Corp. TSBX |
Point72 Asset Management, L.P. | 1,383,314 6.200% |
1,383,314 (New Position) |
Filing History |